MRI-Guided Prostate Interventions.

OBJECTIVE The objective of this study is to discuss the use of MRI-guided and MRI-directed prostate biopsy techniques, describe how interventional MRI focal therapies are used for the treatment of prostate cancer, and predict future directions in prostate interventional MRI. The prospect of establishing a center for prostate imaging, diagnosis, and treatment is also discussed. CONCLUSION Low- or intermediate-risk prostate cancer can be safely treated with MRI-compatible devices and techniques such as biopsy, cryoablation, high-intensity focused ultrasound, or focal laser ablation performed from a transrectal or transperineal approach. Although the long-term effectiveness of focal therapy for prostate cancer is unknown, the effect on urinary or sexual function is extremely low. These procedures are attracting an increasing number of men who view focal therapies as a better alternative to the uncertainty of no therapy and the more radical whole-gland surgical and radiation therapies with their higher complication rates.

[1]  B. Reid,et al.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening , 2016, Journal of cellular physiology.

[2]  D. Margolis,et al.  Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. , 2016, The Journal of urology.

[3]  Yousef Mazaheri,et al.  Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. , 2016, AJR. American journal of roentgenology.

[4]  Stephanie L. Lee,et al.  ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[5]  Walter Kucharczyk,et al.  Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes. , 2015, AJR. American journal of roentgenology.

[6]  E. Schaeffer,et al.  Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience , 2015, The Prostate.

[7]  J. Barentsz,et al.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.

[8]  M. Cooperberg,et al.  Updated trends in imaging use in men diagnosed with prostate cancer , 2014, Prostate Cancer and Prostatic Disease.

[9]  Hessel Wijkstra,et al.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.

[10]  J. Felmlee,et al.  Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. , 2013, Urology.

[11]  J. Bomers,et al.  MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. , 2013, Radiology.

[12]  P. Choyke,et al.  Magnetic resonance imaging (MRI)‐guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI‐based moulds , 2013, BJU international.

[13]  Yipeng Hu,et al.  Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system , 2013, BJU international.

[14]  A. Oto,et al.  MR imaging-guided focal laser ablation for prostate cancer: phase I trial. , 2013, Radiology.

[15]  Robert A Weersink,et al.  Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[16]  W. Travis,et al.  New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Cooperberg,et al.  Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis , 2013, BJU international.

[18]  Carlo Catalano,et al.  Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. , 2013, European urology.

[19]  Matthias Günther,et al.  High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. , 2012, Zeitschrift fur medizinische Physik.

[20]  Rajiv Chopra,et al.  MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. , 2012, Radiology.

[21]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[22]  W. Linehan,et al.  Image guidance in the focal treatment of prostate cancer , 2012, Current opinion in urology.

[23]  Osamu Ukimura,et al.  Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. , 2012, European urology.

[24]  J. Ward,et al.  Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry , 2012, BJU international.

[25]  A. Ouzzane,et al.  Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future , 2012, Advances in urology.

[26]  A. Gangi,et al.  Percutaneous MR-guided cryoablation of prostate cancer: initial experience , 2012, European Radiology.

[27]  L. Norton,et al.  Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. , 2012, Cancer research.

[28]  F. Grizzi,et al.  Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling , 2011, BJU international.

[29]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[30]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[31]  H. Hricak,et al.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.

[32]  H. Ahmed,et al.  Focal therapy for localized prostate cancer: a phase I/II trial. , 2011, The Journal of urology.

[33]  M. Bronskill,et al.  MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. , 2010, Urology.

[34]  Nathan Lawrentschuk,et al.  Focal therapy in prostate cancer: modalities, findings and future considerations , 2010, Nature Reviews Urology.

[35]  R. Passariello,et al.  Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA) , 2010, La radiologia medica.

[36]  C. Lallas,et al.  Hormone therapy in the management of prostate cancer: evidence-based approaches , 2010, Therapeutic advances in urology.

[37]  T. H. van der Kwast,et al.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.

[38]  Matthew R Cooperberg,et al.  Time trends and local variation in primary treatment of localized prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  David C. Miller,et al.  Primary and salvage cryotherapy for prostate cancer. , 2010, The Urologic clinics of North America.

[40]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[41]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[42]  Hashim Uddin Ahmed,et al.  The index lesion and the origin of prostate cancer. , 2009, The New England journal of medicine.

[43]  David P. Smith,et al.  Quality of life three years after diagnosis of localised prostate cancer: population based cohort study , 2009, BMJ : British Medical Journal.

[44]  Yujun Guo,et al.  Image Registration Accuracy of a 3‐Dimensional Transrectal Ultrasound–Guided Prostate Biopsy System , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[45]  A Fenster,et al.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial. , 2009, The Journal of urology.

[46]  Andrew J Vickers,et al.  Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Jun Luo,et al.  Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.

[48]  Rajiv Chopra,et al.  Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback , 2009, Physics in medicine and biology.

[49]  L. Holmberg,et al.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. , 2008, Journal of the National Cancer Institute.

[50]  I. Tuerk,et al.  Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis. , 2008, European urology.

[51]  John T. Wei,et al.  Quality of life and satisfaction with outcome among prostate-cancer survivors. , 2008, The New England journal of medicine.

[52]  Kim Butts Pauly,et al.  Echo combination to reduce proton resonance frequency (PRF) thermometry errors from fat , 2008, Journal of magnetic resonance imaging : JMRI.

[53]  P. Scardino,et al.  1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens , 2006 .

[54]  Thomas Kahn,et al.  Interventional and intraoperative MR: review and update of techniques and clinical experience , 2004, European Radiology.

[55]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[56]  Ashok Gowda,et al.  MR thermometry‐based feedback control of laser interstitial thermal therapy at 980 nm , 2004, Lasers in surgery and medicine.

[57]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[58]  P. Walsh,et al.  Dr. Patrick Walsh's Guide to Surviving Prostate Cancer , 2001 .

[59]  K. Shinohara,et al.  Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. , 2001, Urology.

[60]  K. Kuroda,et al.  A precise and fast temperature mapping using water proton chemical shift , 1995, Magnetic resonance in medicine.

[61]  Boris Rubinsky,et al.  Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.

[62]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[63]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[64]  S. Berndt,et al.  Letters to the Editor/Errata Re: Complications after Prostate Biopsy: Data from SEER-Medicare , 2012 .

[65]  M. Porena,et al.  Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: Past, present, and future , 2010, Indian journal of urology : IJU : journal of the Urological Society of India.